Magellan Health Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Magellan Health (MGLN) Misses Q1 EPS by 15c, Revenues Beat; Affirms FY19 EPS Mid-Point Guidance Above Consensus, Lowers FY19 Revenue Views Below Consensus
May 2, 2019 6:35 AM EDTMagellan Health (NASDAQ: MGLN) reported Q1 EPS of $0.40, $0.15 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $1.8 billion versus the consensus estimate of $1.74 billion.
For First Quarter:
Net revenue decreased 3.6 percent over the first quarter of 2018 to $1.7 billion.Net income decreased 96.2 percent over the first quarter of 2018 to $0.4 million.Segment profit decreased 18 percent... More